These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 30237839)
1. Recommendations for the safe use and handling of oral anticancer drugs in community pharmacy: A pan-Canadian consensus guideline. Vu K; Emberley P; Brown E; Abbott R; Bates JJ; Bourrier V; Djordjevic K; Greenall J; Leung M; Pasetka M; Paquet L; Logan H Can Pharm J (Ott); 2018; 151(4):240-253. PubMed ID: 30237839 [No Abstract] [Full Text] [Related]
2. Developing recommendations for the safe handling of oral anti-cancer drugs in community pharmacies: A pan-Canadian consensus approach. Vu K; Emberley P; Brown E; Abbott R; Bates J; Bourrier V; Djordjevic K; Greenall J; Leung M; Pasetka M; Paquet L; Logan H J Oncol Pharm Pract; 2019 Apr; 25(3):674-688. PubMed ID: 30200843 [TBL] [Abstract][Full Text] [Related]
4. [The Necessity and the Current Status of Safe Handling of Anticancer Drugs]. Kanda K Gan To Kagaku Ryoho; 2017 Jul; 44(7):545-549. PubMed ID: 28790253 [TBL] [Abstract][Full Text] [Related]
5. Safe handling of cytotoxics: guideline recommendations. Easty AC; Coakley N; Cheng R; Cividino M; Savage P; Tozer R; White RE Curr Oncol; 2015 Feb; 22(1):e27-37. PubMed ID: 25684994 [TBL] [Abstract][Full Text] [Related]
6. Patients' perspectives and safe handling of oral anticancer drugs at an Asian cancer center. Chan A; Leow YC; Sim MH J Oncol Pharm Pract; 2009 Sep; 15(3):161-5. PubMed ID: 19171555 [TBL] [Abstract][Full Text] [Related]
7. Monitoring contamination of hazardous drug compounding surfaces at hospital pharmacy departments. A consensus Statement. Practice guidelines of the Spanish Society of Hospital Pharmacists (SEFH). Valero-García S; González-Haba E; Gorgas-Torner MQ; Alonso-Herreros JM; Cercós Lletí AC; Poveda-Andrés JL; Calleja-Hernandez MÁ; Delgado-Sánchez O Farm Hosp; 2021 Mar; 45(2):96-107. PubMed ID: 33709894 [TBL] [Abstract][Full Text] [Related]
9. [Health risks of occupational exposure to anticancer (antineoplastic) drugs in health care workers]. Tomioka K; Kumagai S Sangyo Eiseigaku Zasshi; 2005 Sep; 47(5):195-203. PubMed ID: 16262141 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of community pharmacist ability to ensure the safe use of oral anticancer agents: a nationwide survey in Japan. Suzuki S; Abbott R; Sakurai H; Kawasumi K; Johnson PE; Tahara M; Yamaguchi M; Saito S; Yee GC; Endo K Jpn J Clin Oncol; 2017 May; 47(5):413-421. PubMed ID: 28184436 [TBL] [Abstract][Full Text] [Related]
11. [Safe Handling of Cancer Chemotherapy Drugs in Pharmacy(Preparations, Transport and Safe Deposit)]. Nomura H Gan To Kagaku Ryoho; 2017 Jul; 44(7):554-557. PubMed ID: 28790255 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of handling, storage, and disposal practices of oral anticancer medications among cancer patients and their caregivers at home setting in the Princess Noorah Oncology Center. Algethami AA; Alshamrani MA; AlHarbi AM; AlAzmi AA; Khan MA; AlHadidi RA J Oncol Pharm Pract; 2021 Jan; 27(1):20-25. PubMed ID: 32151186 [TBL] [Abstract][Full Text] [Related]
13. Closed-system drug-transfer devices plus safe handling of hazardous drugs versus safe handling alone for reducing exposure to infusional hazardous drugs in healthcare staff. Gurusamy KS; Best LM; Tanguay C; Lennan E; Korva M; Bussières JF Cochrane Database Syst Rev; 2018 Mar; 3(3):CD012860. PubMed ID: 29582940 [TBL] [Abstract][Full Text] [Related]
14. Adherence to national recommendations for safe methotrexate dispensing in community pharmacies. Koster ES; Walgers JC; van Grinsven MC; Winters NA; Bouvy ML J Manag Care Pharm; 2014 Feb; 20(2):194-200. PubMed ID: 24456321 [TBL] [Abstract][Full Text] [Related]
15. Canadian Contraception Consensus (Part 2 of 4). Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N J Obstet Gynaecol Can; 2015 Nov; 37(11):1033-9. PubMed ID: 26629725 [TBL] [Abstract][Full Text] [Related]
16. Creating an Interprofessional guideline to support patients receiving oral anticoagulation therapy: a Delphi exercise. Damen NL; Van den Bemt BJF; Hersberger KE; Papastergiou J; Alves da Costa F; Rydant S; Wartenberg NS; Lobban T; Arnet I; Antoniou S; Int J Clin Pharm; 2019 Aug; 41(4):1012-1020. PubMed ID: 31093940 [TBL] [Abstract][Full Text] [Related]
17. [Recommendations for using oral antineoplastic and immunomodulating agents in oncohematology by enteral tube administration]. Crespo Martínez CL; Romero Jiménez RM; Vázquez-López C; Pérez-Cordón L; Vallinas Hidalgo S; Bravo José P Nutr Hosp; 2022 Feb; 39(1):171-201. PubMed ID: 34538058 [TBL] [Abstract][Full Text] [Related]
18. Towards safety of oral anti-cancer agents, the need to educate our pharmacists. Mekdad SS; AlSayed AD Saudi Pharm J; 2017 Jan; 25(1):136-140. PubMed ID: 28223874 [No Abstract] [Full Text] [Related]
19. The development of evidence-based guidelines for over-the-counter treatment of vulvovaginal candidiasis. Bond CM; Watson MC; Pharm World Sci; 2003 Aug; 25(4):177-81. PubMed ID: 12964498 [TBL] [Abstract][Full Text] [Related]
20. Australian consensus guidelines for the safe handling of monoclonal antibodies for cancer treatment by healthcare personnel. Alexander M; King J; Bajel A; Doecke C; Fox P; Lingaratnam S; Mellor JD; Nicholson L; Roos I; Saunders T; Wilkes J; Zielinski R; Byrne J; MacMillan K; Mollo A; Kirsa S; Green M Intern Med J; 2014 Oct; 44(10):1018-26. PubMed ID: 25302720 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]